Global Subcutaneous Drug Delivery Equipment Market Insights and Forecast to 2026

Publisher Name :
Date: 14-Jul-2020
No. of pages: 115
Inquire Before Buying

Subcutaneous Drug Delivery Equipment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Subcutaneous Drug Delivery Equipment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Subcutaneous Drug Delivery Equipment market is segmented into

- Syringe Based Subcutaneous Drug Delivery

- Subcutaneous Implants

- Pen Systems for Subcutaneous Drug Delivery

- Auto Injectors

- Pump Based Drug Delivery Systems

Segment by Application, the Subcutaneous Drug Delivery Equipment market is segmented into

- In-Patient

- Out-Patient

- Clinic

- Others

Regional and Country-level Analysis

The Subcutaneous Drug Delivery Equipment market is analysed and market size information is provided by regions (countries).

The key regions covered in the Subcutaneous Drug Delivery Equipment market report are North America, Europe, China and Japan. It also covers key regions (countries), viz, the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.

The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of production capacity, price and revenue for the period 2015-2026.

Competitive Landscape and Subcutaneous Drug Delivery Equipment Market Share Analysis

Subcutaneous Drug Delivery Equipment market competitive landscape provides details and data information by manufacturers. The report offers comprehensive analysis and accurate statistics on production capacity, price, revenue of Subcutaneous Drug Delivery Equipment by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on production, revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue, and the production capacity, price, revenue generated in Subcutaneous Drug Delivery Equipment business, the date to enter into the Subcutaneous Drug Delivery Equipment market, Subcutaneous Drug Delivery Equipment product introduction, recent developments, etc.

The major vendors covered:

- Boehringer Ingelheim

- Eli Lily

- Galaxo

- HMD pharmaceuticals

- Merck

- Novartis

- Novo Nordisk

- Pfizer

- Sanofi

- Teva Pharmaceutical

- Zogenix

Global Subcutaneous Drug Delivery Equipment Market Insights and Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Subcutaneous Drug Delivery Equipment Product Introduction
1.2 Key Market Segments in This Study
1.3 Key Manufacturers Covered: Ranking of Global Top Subcutaneous Drug Delivery Equipment Manufacturers by Revenue in 2019
1.4 Market by Type
1.4.1 Global Subcutaneous Drug Delivery Equipment Market Size Growth Rate by Type
1.4.2 Syringe Based Subcutaneous Drug Delivery
1.4.3 Subcutaneous Implants
1.4.4 Pen Systems for Subcutaneous Drug Delivery
1.4.5 Auto Injectors
1.4.6 Pump Based Drug Delivery Systems
1.5 Market by Application
1.5.1 Global Subcutaneous Drug Delivery Equipment Market Size Growth Rate by Application
1.5.2 In-Patient
1.5.3 Out-Patient
1.5.4 Clinic
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Subcutaneous Drug Delivery Equipment Market Size, Estimates and Forecasts
2.1.1 Global Subcutaneous Drug Delivery Equipment Revenue Estimates and Forecasts 2015-2026
2.1.2 Global Subcutaneous Drug Delivery Equipment Production Capacity Estimates and Forecasts 2015-2026
2.1.3 Global Subcutaneous Drug Delivery Equipment Production Estimates and Forecasts 2015-2026
2.2 Global Subcutaneous Drug Delivery Equipment, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Analysis of Competitive Landscape
2.3.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
2.3.2 Global Subcutaneous Drug Delivery Equipment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.3.3 Global Subcutaneous Drug Delivery Equipment Manufacturers Geographical Distribution
2.4 Key Trends for Subcutaneous Drug Delivery Equipment Markets & Products
2.5 Primary Interviews with Key Subcutaneous Drug Delivery Equipment Players (Opinion Leaders)
3 Market Size by Manufacturers
3.1 Global Top Subcutaneous Drug Delivery Equipment Manufacturers by Production Capacity
3.1.1 Global Top Subcutaneous Drug Delivery Equipment Manufacturers by Production Capacity (2015-2020)
3.1.2 Global Top Subcutaneous Drug Delivery Equipment Manufacturers by Production (2015-2020)
3.1.3 Global Top Subcutaneous Drug Delivery Equipment Manufacturers Market Share by Production
3.2 Global Top Subcutaneous Drug Delivery Equipment Manufacturers by Revenue
3.2.1 Global Top Subcutaneous Drug Delivery Equipment Manufacturers by Revenue (2015-2020)
3.2.2 Global Top Subcutaneous Drug Delivery Equipment Manufacturers Market Share by Revenue (2015-2020)
3.2.3 Global Top 10 and Top 5 Companies by Subcutaneous Drug Delivery Equipment Revenue in 2019
3.3 Global Subcutaneous Drug Delivery Equipment Price by Manufacturers
3.4 Mergers & Acquisitions, Expansion Plans
4 Subcutaneous Drug Delivery Equipment Production by Regions
4.1 Global Subcutaneous Drug Delivery Equipment Historic Market Facts & Figures by Regions
4.1.1 Global Top Subcutaneous Drug Delivery Equipment Regions by Production (2015-2020)
4.1.2 Global Top Subcutaneous Drug Delivery Equipment Regions by Revenue (2015-2020)
4.2 North America
4.2.1 North America Subcutaneous Drug Delivery Equipment Production (2015-2020)
4.2.2 North America Subcutaneous Drug Delivery Equipment Revenue (2015-2020)
4.2.3 Key Players in North America
4.2.4 North America Subcutaneous Drug Delivery Equipment Import & Export (2015-2020)
4.3 Europe
4.3.1 Europe Subcutaneous Drug Delivery Equipment Production (2015-2020)
4.3.2 Europe Subcutaneous Drug Delivery Equipment Revenue (2015-2020)
4.3.3 Key Players in Europe
4.3.4 Europe Subcutaneous Drug Delivery Equipment Import & Export (2015-2020)
4.4 China
4.4.1 China Subcutaneous Drug Delivery Equipment Production (2015-2020)
4.4.2 China Subcutaneous Drug Delivery Equipment Revenue (2015-2020)
4.4.3 Key Players in China
4.4.4 China Subcutaneous Drug Delivery Equipment Import & Export (2015-2020)
4.5 Japan
4.5.1 Japan Subcutaneous Drug Delivery Equipment Production (2015-2020)
4.5.2 Japan Subcutaneous Drug Delivery Equipment Revenue (2015-2020)
4.5.3 Key Players in Japan
4.5.4 Japan Subcutaneous Drug Delivery Equipment Import & Export (2015-2020)
5 Subcutaneous Drug Delivery Equipment Consumption by Region
5.1 Global Top Subcutaneous Drug Delivery Equipment Regions by Consumption
5.1.1 Global Top Subcutaneous Drug Delivery Equipment Regions by Consumption (2015-2020)
5.1.2 Global Top Subcutaneous Drug Delivery Equipment Regions Market Share by Consumption (2015-2020)
5.2 North America
5.2.1 North America Subcutaneous Drug Delivery Equipment Consumption by Application
5.2.2 North America Subcutaneous Drug Delivery Equipment Consumption by Countries
5.2.3 U.S.
5.2.4 Canada
5.3 Europe
5.3.1 Europe Subcutaneous Drug Delivery Equipment Consumption by Application
5.3.2 Europe Subcutaneous Drug Delivery Equipment Consumption by Countries
5.3.3 Germany
5.3.4 France
5.3.5 U.K.
5.3.6 Italy
5.3.7 Russia
5.4 Asia Pacific
5.4.1 Asia Pacific Subcutaneous Drug Delivery Equipment Consumption by Application
5.4.2 Asia Pacific Subcutaneous Drug Delivery Equipment Consumption by Regions
5.4.3 China
5.4.4 Japan
5.4.5 South Korea
5.4.6 India
5.4.7 Australia
5.4.8 Taiwan
5.4.9 Indonesia
5.4.10 Thailand
5.4.11 Malaysia
5.4.12 Philippines
5.4.13 Vietnam
5.5 Central & South America
5.5.1 Central & South America Subcutaneous Drug Delivery Equipment Consumption by Application
5.5.2 Central & South America Subcutaneous Drug Delivery Equipment Consumption by Country
5.5.3 Mexico
5.5.3 Brazil
5.5.3 Argentina
5.6 Middle East and Africa
5.6.1 Middle East and Africa Subcutaneous Drug Delivery Equipment Consumption by Application
5.6.2 Middle East and Africa Subcutaneous Drug Delivery Equipment Consumption by Countries
5.6.3 Turkey
5.6.4 Saudi Arabia
5.6.5 U.A.E
6 Market Size by Type (2015-2026)
6.1 Global Subcutaneous Drug Delivery Equipment Market Size by Type (2015-2020)
6.1.1 Global Subcutaneous Drug Delivery Equipment Production by Type (2015-2020)
6.1.2 Global Subcutaneous Drug Delivery Equipment Revenue by Type (2015-2020)
6.1.3 Subcutaneous Drug Delivery Equipment Price by Type (2015-2020)
6.2 Global Subcutaneous Drug Delivery Equipment Market Forecast by Type (2021-2026)
6.2.1 Global Subcutaneous Drug Delivery Equipment Production Forecast by Type (2021-2026)
6.2.2 Global Subcutaneous Drug Delivery Equipment Revenue Forecast by Type (2021-2026)
6.2.3 Global Subcutaneous Drug Delivery Equipment Price Forecast by Type (2021-2026)
6.3 Global Subcutaneous Drug Delivery Equipment Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
7 Market Size by Application (2015-2026)
7.2.1 Global Subcutaneous Drug Delivery Equipment Consumption Historic Breakdown by Application (2015-2020)
7.2.2 Global Subcutaneous Drug Delivery Equipment Consumption Forecast by Application (2021-2026)
8 Corporate Profiles
8.1 Boehringer Ingelheim
8.1.1 Boehringer Ingelheim Corporation Information
8.1.2 Boehringer Ingelheim Overview
8.1.3 Boehringer Ingelheim Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.1.4 Boehringer Ingelheim Product Description
8.1.5 Boehringer Ingelheim Related Developments
8.2 Eli Lily
8.2.1 Eli Lily Corporation Information
8.2.2 Eli Lily Overview
8.2.3 Eli Lily Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.2.4 Eli Lily Product Description
8.2.5 Eli Lily Related Developments
8.3 Galaxo
8.3.1 Galaxo Corporation Information
8.3.2 Galaxo Overview
8.3.3 Galaxo Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.3.4 Galaxo Product Description
8.3.5 Galaxo Related Developments
8.4 HMD pharmaceuticals
8.4.1 HMD pharmaceuticals Corporation Information
8.4.2 HMD pharmaceuticals Overview
8.4.3 HMD pharmaceuticals Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.4.4 HMD pharmaceuticals Product Description
8.4.5 HMD pharmaceuticals Related Developments
8.5 Merck
8.5.1 Merck Corporation Information
8.5.2 Merck Overview
8.5.3 Merck Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.5.4 Merck Product Description
8.5.5 Merck Related Developments
8.6 Novartis
8.6.1 Novartis Corporation Information
8.6.2 Novartis Overview
8.6.3 Novartis Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.6.4 Novartis Product Description
8.6.5 Novartis Related Developments
8.7 Novo Nordisk
8.7.1 Novo Nordisk Corporation Information
8.7.2 Novo Nordisk Overview
8.7.3 Novo Nordisk Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.7.4 Novo Nordisk Product Description
8.7.5 Novo Nordisk Related Developments
8.8 Pfizer
8.8.1 Pfizer Corporation Information
8.8.2 Pfizer Overview
8.8.3 Pfizer Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.8.4 Pfizer Product Description
8.8.5 Pfizer Related Developments
8.9 Sanofi
8.9.1 Sanofi Corporation Information
8.9.2 Sanofi Overview
8.9.3 Sanofi Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.9.4 Sanofi Product Description
8.9.5 Sanofi Related Developments
8.10 Teva Pharmaceutical
8.10.1 Teva Pharmaceutical Corporation Information
8.10.2 Teva Pharmaceutical Overview
8.10.3 Teva Pharmaceutical Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.10.4 Teva Pharmaceutical Product Description
8.10.5 Teva Pharmaceutical Related Developments
8.11 Zogenix
8.11.1 Zogenix Corporation Information
8.11.2 Zogenix Overview
8.11.3 Zogenix Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.11.4 Zogenix Product Description
8.11.5 Zogenix Related Developments
9 Subcutaneous Drug Delivery Equipment Production Forecast by Regions
9.1 Global Top Subcutaneous Drug Delivery Equipment Regions Forecast by Revenue (2021-2026)
9.2 Global Top Subcutaneous Drug Delivery Equipment Regions Forecast by Production (2021-2026)
9.3 Key Subcutaneous Drug Delivery Equipment Production Regions Forecast
9.3.1 North America
9.3.2 Europe
9.3.3 China
9.3.4 Japan
10 Subcutaneous Drug Delivery Equipment Consumption Forecast by Region
10.1 Global Subcutaneous Drug Delivery Equipment Consumption Forecast by Region (2021-2026)
10.2 North America Subcutaneous Drug Delivery Equipment Consumption Forecast by Region (2021-2026)
10.3 Europe Subcutaneous Drug Delivery Equipment Consumption Forecast by Region (2021-2026)
10.4 Asia Pacific Subcutaneous Drug Delivery Equipment Consumption Forecast by Region (2021-2026)
10.5 Latin America Subcutaneous Drug Delivery Equipment Consumption Forecast by Region (2021-2026)
10.6 Middle East and Africa Subcutaneous Drug Delivery Equipment Consumption Forecast by Region (2021-2026)
11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Subcutaneous Drug Delivery Equipment Sales Channels
11.2.2 Subcutaneous Drug Delivery Equipment Distributors
11.3 Subcutaneous Drug Delivery Equipment Customers
12 Market Opportunities & Challenges, Risks and Influences Factors Analysis
12.1 Subcutaneous Drug Delivery Equipment Industry
12.2 Market Trends
12.3 Market Opportunities and Drivers
12.4 Market Challenges
12.5 Subcutaneous Drug Delivery Equipment Market Risks/Restraints
12.6 Porter's Five Forces Analysis
13 Key Finding in The Global Subcutaneous Drug Delivery Equipment Study
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
List of Tables
Table 1. Subcutaneous Drug Delivery Equipment Key Market Segments in This Study
Table 2. Ranking of Global Top Subcutaneous Drug Delivery Equipment Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Subcutaneous Drug Delivery Equipment Market Size Growth Rate by Type 2020-2026 (K Units) (Million US$)
Table 4. Major Manufacturers of Syringe Based Subcutaneous Drug Delivery
Table 5. Major Manufacturers of Subcutaneous Implants
Table 6. Major Manufacturers of Pen Systems for Subcutaneous Drug Delivery
Table 7. Major Manufacturers of Auto Injectors
Table 8. Major Manufacturers of Pump Based Drug Delivery Systems
Table 9. Global Subcutaneous Drug Delivery Equipment Market Size Growth Rate by Application 2020-2026 (K Units)
Table 10. Global Subcutaneous Drug Delivery Equipment Market Size by Region in US$ Million: 2015 VS 2020 VS 2026
Table 11. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 12. Global Subcutaneous Drug Delivery Equipment by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Subcutaneous Drug Delivery Equipment as of 2019)
Table 13. Subcutaneous Drug Delivery Equipment Manufacturing Base Distribution and Headquarters
Table 14. Manufacturers Subcutaneous Drug Delivery Equipment Product Offered
Table 15. Date of Manufacturers Enter into Subcutaneous Drug Delivery Equipment Market
Table 16. Key Trends for Subcutaneous Drug Delivery Equipment Markets & Products
Table 17. Main Points Interviewed from Key Subcutaneous Drug Delivery Equipment Players
Table 18. Global Subcutaneous Drug Delivery Equipment Production Capacity by Manufacturers (2015-2020) (K Units)
Table 19. Global Subcutaneous Drug Delivery Equipment Production Share by Manufacturers (2015-2020)
Table 20. Subcutaneous Drug Delivery Equipment Revenue by Manufacturers (2015-2020) (Million US$)
Table 21. Subcutaneous Drug Delivery Equipment Revenue Share by Manufacturers (2015-2020)
Table 22. Subcutaneous Drug Delivery Equipment Price by Manufacturers 2015-2020 (USD/Unit)
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Subcutaneous Drug Delivery Equipment Production by Regions (2015-2020) (K Units)
Table 25. Global Subcutaneous Drug Delivery Equipment Production Market Share by Regions (2015-2020)
Table 26. Global Subcutaneous Drug Delivery Equipment Revenue by Regions (2015-2020) (US$ Million)
Table 27. Global Subcutaneous Drug Delivery Equipment Revenue Market Share by Regions (2015-2020)
Table 28. Key Subcutaneous Drug Delivery Equipment Players in North America
Table 29. Import & Export of Subcutaneous Drug Delivery Equipment in North America (K Units)
Table 30. Key Subcutaneous Drug Delivery Equipment Players in Europe
Table 31. Import & Export of Subcutaneous Drug Delivery Equipment in Europe (K Units)
Table 32. Key Subcutaneous Drug Delivery Equipment Players in China
Table 33. Import & Export of Subcutaneous Drug Delivery Equipment in China (K Units)
Table 34. Key Subcutaneous Drug Delivery Equipment Players in Japan
Table 35. Import & Export of Subcutaneous Drug Delivery Equipment in Japan (K Units)
Table 36. Global Subcutaneous Drug Delivery Equipment Consumption by Regions (2015-2020) (K Units)
Table 37. Global Subcutaneous Drug Delivery Equipment Consumption Market Share by Regions (2015-2020)
Table 38. North America Subcutaneous Drug Delivery Equipment Consumption by Application (2015-2020) (K Units)
Table 39. North America Subcutaneous Drug Delivery Equipment Consumption by Countries (2015-2020) (K Units)
Table 40. Europe Subcutaneous Drug Delivery Equipment Consumption by Application (2015-2020) (K Units)
Table 41. Europe Subcutaneous Drug Delivery Equipment Consumption by Countries (2015-2020) (K Units)
Table 42. Asia Pacific Subcutaneous Drug Delivery Equipment Consumption by Application (2015-2020) (K Units)
Table 43. Asia Pacific Subcutaneous Drug Delivery Equipment Consumption Market Share by Application (2015-2020) (K Units)
Table 44. Asia Pacific Subcutaneous Drug Delivery Equipment Consumption by Regions (2015-2020) (K Units)
Table 45. Latin America Subcutaneous Drug Delivery Equipment Consumption by Application (2015-2020) (K Units)
Table 46. Latin America Subcutaneous Drug Delivery Equipment Consumption by Countries (2015-2020) (K Units)
Table 47. Middle East and Africa Subcutaneous Drug Delivery Equipment Consumption by Application (2015-2020) (K Units)
Table 48. Middle East and Africa Subcutaneous Drug Delivery Equipment Consumption by Countries (2015-2020) (K Units)
Table 49. Global Subcutaneous Drug Delivery Equipment Production by Type (2015-2020) (K Units)
Table 50. Global Subcutaneous Drug Delivery Equipment Production Share by Type (2015-2020)
Table 51. Global Subcutaneous Drug Delivery Equipment Revenue by Type (2015-2020) (Million US$)
Table 52. Global Subcutaneous Drug Delivery Equipment Revenue Share by Type (2015-2020)
Table 53. Subcutaneous Drug Delivery Equipment Price by Type 2015-2020 (USD/Unit)
Table 54. Global Subcutaneous Drug Delivery Equipment Consumption by Application (2015-2020) (K Units)
Table 55. Global Subcutaneous Drug Delivery Equipment Consumption Share by Application (2015-2020)
Table 56. Boehringer Ingelheim Corporation Information
Table 57. Boehringer Ingelheim Description and Major Businesses
Table 58. Boehringer Ingelheim Subcutaneous Drug Delivery Equipment Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 59. Boehringer Ingelheim Product
Table 60. Boehringer Ingelheim Recent Development
Table 61. Eli Lily Corporation Information
Table 62. Eli Lily Description and Major Businesses
Table 63. Eli Lily Subcutaneous Drug Delivery Equipment Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 64. Eli Lily Product
Table 65. Eli Lily Recent Development
Table 66. Galaxo Corporation Information
Table 67. Galaxo Description and Major Businesses
Table 68. Galaxo Subcutaneous Drug Delivery Equipment Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 69. Galaxo Product
Table 70. Galaxo Recent Development
Table 71. HMD pharmaceuticals Corporation Information
Table 72. HMD pharmaceuticals Description and Major Businesses
Table 73. HMD pharmaceuticals Subcutaneous Drug Delivery Equipment Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 74. HMD pharmaceuticals Product
Table 75. HMD pharmaceuticals Recent Development
Table 76. Merck Corporation Information
Table 77. Merck Description and Major Businesses
Table 78. Merck Subcutaneous Drug Delivery Equipment Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 79. Merck Product
Table 80. Merck Recent Development
Table 81. Novartis Corporation Information
Table 82. Novartis Description and Major Businesses
Table 83. Novartis Subcutaneous Drug Delivery Equipment Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 84. Novartis Product
Table 85. Novartis Recent Development
Table 86. Novo Nordisk Corporation Information
Table 87. Novo Nordisk Description and Major Businesses
Table 88. Novo Nordisk Subcutaneous Drug Delivery Equipment Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 89. Novo Nordisk Product
Table 90. Novo Nordisk Recent Development
Table 91. Pfizer Corporation Information
Table 92. Pfizer Description and Major Businesses
Table 93. Pfizer Subcutaneous Drug Delivery Equipment Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 94. Pfizer Product
Table 95. Pfizer Recent Development
Table 96. Sanofi Corporation Information
Table 97. Sanofi Description and Major Businesses
Table 98. Sanofi Subcutaneous Drug Delivery Equipment Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 99. Sanofi Product
Table 100. Sanofi Recent Development
Table 101. Teva Pharmaceutical Corporation Information
Table 102. Teva Pharmaceutical Description and Major Businesses
Table 103. Teva Pharmaceutical Subcutaneous Drug Delivery Equipment Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 104. Teva Pharmaceutical Product
Table 105. Teva Pharmaceutical Recent Development
Table 106. Zogenix Corporation Information
Table 107. Zogenix Description and Major Businesses
Table 108. Zogenix Subcutaneous Drug Delivery Equipment Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 109. Zogenix Product
Table 110. Zogenix Recent Development
Table 111. Global Subcutaneous Drug Delivery Equipment Revenue Forecast by Region (2021-2026) (Million US$)
Table 112. Global Subcutaneous Drug Delivery Equipment Production Forecast by Regions (2021-2026) (K Units)
Table 113. Global Subcutaneous Drug Delivery Equipment Production Forecast by Type (2021-2026) (K Units)
Table 114. Global Subcutaneous Drug Delivery Equipment Revenue Forecast by Type (2021-2026) (Million US$)
Table 115. North America Subcutaneous Drug Delivery Equipment Consumption Forecast by Regions (2021-2026) (K Units)
Table 116. Europe Subcutaneous Drug Delivery Equipment Consumption Forecast by Regions (2021-2026) (K Units)
Table 117. Asia Pacific Subcutaneous Drug Delivery Equipment Consumption Forecast by Regions (2021-2026) (K Units)
Table 118. Latin America Subcutaneous Drug Delivery Equipment Consumption Forecast by Regions (2021-2026) (K Units)
Table 119. Middle East and Africa Subcutaneous Drug Delivery Equipment Consumption Forecast by Regions (2021-2026) (K Units)
Table 120. Subcutaneous Drug Delivery Equipment Distributors List
Table 121. Subcutaneous Drug Delivery Equipment Customers List
Table 122. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 123. Key Challenges
Table 124. Market Risks
Table 125. Research Programs/Design for This Report
Table 126. Key Data Information from Secondary Sources
Table 127. Key Data Information from Primary Sources
List of Figures
Figure 1. Subcutaneous Drug Delivery Equipment Product Picture
Figure 2. Global Subcutaneous Drug Delivery Equipment Production Market Share by Type in 2020 & 2026
Figure 3. Syringe Based Subcutaneous Drug Delivery Product Picture
Figure 4. Subcutaneous Implants Product Picture
Figure 5. Pen Systems for Subcutaneous Drug Delivery Product Picture
Figure 6. Auto Injectors Product Picture
Figure 7. Pump Based Drug Delivery Systems Product Picture
Figure 8. Global Subcutaneous Drug Delivery Equipment Consumption Market Share by Application in 2020 & 2026
Figure 9. In-Patient
Figure 10. Out-Patient
Figure 11. Clinic
Figure 12. Others
Figure 13. Subcutaneous Drug Delivery Equipment Report Years Considered
Figure 14. Global Subcutaneous Drug Delivery Equipment Revenue 2015-2026 (Million US$)
Figure 15. Global Subcutaneous Drug Delivery Equipment Production Capacity 2015-2026 (K Units)
Figure 16. Global Subcutaneous Drug Delivery Equipment Production 2015-2026 (K Units)
Figure 17. Global Subcutaneous Drug Delivery Equipment Market Share Scenario by Region in Percentage: 2020 Versus 2026
Figure 18. Subcutaneous Drug Delivery Equipment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 19. Global Subcutaneous Drug Delivery Equipment Production Share by Manufacturers in 2015
Figure 20. The Top 10 and Top 5 Players Market Share by Subcutaneous Drug Delivery Equipment Revenue in 2019
Figure 21. Global Subcutaneous Drug Delivery Equipment Production Market Share by Region (2015-2020)
Figure 22. Subcutaneous Drug Delivery Equipment Production Growth Rate in North America (2015-2020) (K Units)
Figure 23. Subcutaneous Drug Delivery Equipment Revenue Growth Rate in North America (2015-2020) (US$ Million)
Figure 24. Subcutaneous Drug Delivery Equipment Production Growth Rate in Europe (2015-2020) (K Units)
Figure 25. Subcutaneous Drug Delivery Equipment Revenue Growth Rate in Europe (2015-2020) (US$ Million)
Figure 26. Subcutaneous Drug Delivery Equipment Production Growth Rate in China (2015-2020) (K Units)
Figure 27. Subcutaneous Drug Delivery Equipment Revenue Growth Rate in China (2015-2020) (US$ Million)
Figure 28. Subcutaneous Drug Delivery Equipment Production Growth Rate in Japan (2015-2020) (K Units)
Figure 29. Subcutaneous Drug Delivery Equipment Revenue Growth Rate in Japan (2015-2020) (US$ Million)
Figure 30. Global Subcutaneous Drug Delivery Equipment Consumption Market Share by Regions 2015-2020
Figure 31. North America Subcutaneous Drug Delivery Equipment Consumption and Growth Rate (2015-2020) (K Units)
Figure 32. North America Subcutaneous Drug Delivery Equipment Consumption Market Share by Application in 2019
Figure 33. North America Subcutaneous Drug Delivery Equipment Consumption Market Share by Countries in 2019
Figure 34. U.S. Subcutaneous Drug Delivery Equipment Consumption and Growth Rate (2015-2020) (K Units)
Figure 35. Canada Subcutaneous Drug Delivery Equipment Consumption and Growth Rate (2015-2020) (K Units)
Figure 36. Europe Subcutaneous Drug Delivery Equipment Consumption and Growth Rate (2015-2020) (K Units)
Figure 37. Europe Subcutaneous Drug Delivery Equipment Consumption Market Share by Application in 2019
Figure 38. Europe Subcutaneous Drug Delivery Equipment Consumption Market Share by Countries in 2019
Figure 39. Germany Subcutaneous Drug Delivery Equipment Consumption and Growth Rate (2015-2020) (K Units)
Figure 40. France Subcutaneous Drug Delivery Equipment Consumption and Growth Rate (2015-2020) (K Units)
Figure 41. U.K. Subcutaneous Drug Delivery Equipment Consumption and Growth Rate (2015-2020) (K Units)
Figure 42. Italy Subcutaneous Drug Delivery Equipment Consumption and Growth Rate (2015-2020) (K Units)
Figure 43. Russia Subcutaneous Drug Delivery Equipment Consumption and Growth Rate (2015-2020) (K Units)
Figure 44. Asia Pacific Subcutaneous Drug Delivery Equipment Consumption and Growth Rate (K Units)
Figure 45. Asia Pacific Subcutaneous Drug Delivery Equipment Consumption Market Share by Application in 2019
Figure 46. Asia Pacific Subcutaneous Drug Delivery Equipment Consumption Market Share by Regions in 2019
Figure 47. China Subcutaneous Drug Delivery Equipment Consumption and Growth Rate (2015-2020) (K Units)
Figure 48. Japan Subcutaneous Drug Delivery Equipment Consumption and Growth Rate (2015-2020) (K Units)
Figure 49. South Korea Subcutaneous Drug Delivery Equipment Consumption and Growth Rate (2015-2020) (K Units)
Figure 50. India Subcutaneous Drug Delivery Equipment Consumption and Growth Rate (2015-2020) (K Units)
Figure 51. Australia Subcutaneous Drug Delivery Equipment Consumption and Growth Rate (2015-2020) (K Units)
Figure 52. Taiwan Subcutaneous Drug Delivery Equipment Consumption and Growth Rate (2015-2020) (K Units)
Figure 53. Indonesia Subcutaneous Drug Delivery Equipment Consumption and Growth Rate (2015-2020) (K Units)
Figure 54. Thailand Subcutaneous Drug Delivery Equipment Consumption and Growth Rate (2015-2020) (K Units)
Figure 55. Malaysia Subcutaneous Drug Delivery Equipment Consumption and Growth Rate (2015-2020) (K Units)
Figure 56. Philippines Subcutaneous Drug Delivery Equipment Consumption and Growth Rate (2015-2020) (K Units)
Figure 57. Vietnam Subcutaneous Drug Delivery Equipment Consumption and Growth Rate (2015-2020) (K Units)
Figure 58. Latin America Subcutaneous Drug Delivery Equipment Consumption and Growth Rate (K Units)
Figure 59. Latin America Subcutaneous Drug Delivery Equipment Consumption Market Share by Application in 2019
Figure 60. Latin America Subcutaneous Drug Delivery Equipment Consumption Market Share by Countries in 2019
Figure 61. Mexico Subcutaneous Drug Delivery Equipment Consumption and Growth Rate (2015-2020) (K Units)
Figure 62. Brazil Subcutaneous Drug Delivery Equipment Consumption and Growth Rate (2015-2020) (K Units)
Figure 63. Argentina Subcutaneous Drug Delivery Equipment Consumption and Growth Rate (2015-2020) (K Units)
Figure 64. Middle East and Africa Subcutaneous Drug Delivery Equipment Consumption and Growth Rate (K Units)
Figure 65. Middle East and Africa Subcutaneous Drug Delivery Equipment Consumption Market Share by Application in 2019
Figure 66. Middle East and Africa Subcutaneous Drug Delivery Equipment Consumption Market Share by Countries in 2019
Figure 67. Turkey Subcutaneous Drug Delivery Equipment Consumption and Growth Rate (2015-2020) (K Units)
Figure 68. Saudi Arabia Subcutaneous Drug Delivery Equipment Consumption and Growth Rate (2015-2020) (K Units)
Figure 69. U.A.E Subcutaneous Drug Delivery Equipment Consumption and Growth Rate (2015-2020) (K Units)
Figure 70. Global Subcutaneous Drug Delivery Equipment Production Market Share by Type (2015-2020)
Figure 71. Global Subcutaneous Drug Delivery Equipment Production Market Share by Type in 2019
Figure 72. Global Subcutaneous Drug Delivery Equipment Revenue Market Share by Type (2015-2020)
Figure 73. Global Subcutaneous Drug Delivery Equipment Revenue Market Share by Type in 2019
Figure 74. Global Subcutaneous Drug Delivery Equipment Production Market Share Forecast by Type (2021-2026)
Figure 75. Global Subcutaneous Drug Delivery Equipment Revenue Market Share Forecast by Type (2021-2026)
Figure 76. Global Subcutaneous Drug Delivery Equipment Market Share by Price Range (2015-2020)
Figure 77. Global Subcutaneous Drug Delivery Equipment Consumption Market Share by Application (2015-2020)
Figure 78. Global Subcutaneous Drug Delivery Equipment Value (Consumption) Market Share by Application (2015-2020)
Figure 79. Global Subcutaneous Drug Delivery Equipment Consumption Market Share Forecast by Application (2021-2026)
Figure 80. Global Subcutaneous Drug Delivery Equipment Revenue Forecast by Regions (2021-2026) (US$ Million)
Figure 81. Global Subcutaneous Drug Delivery Equipment Revenue Market Share Forecast by Regions ((2021-2026))
Figure 82. Global Subcutaneous Drug Delivery Equipment Production Forecast by Regions (2021-2026) (K Units)
Figure 83. North America Subcutaneous Drug Delivery Equipment Production Forecast (2021-2026) (K Units)
Figure 84. North America Subcutaneous Drug Delivery Equipment Revenue Forecast (2021-2026) (US$ Million)
Figure 85. Europe Subcutaneous Drug Delivery Equipment Production Forecast (2021-2026) (K Units)
Figure 86. Europe Subcutaneous Drug Delivery Equipment Revenue Forecast (2021-2026) (US$ Million)
Figure 87. China Subcutaneous Drug Delivery Equipment Production Forecast (2021-2026) (K Units)
Figure 88. China Subcutaneous Drug Delivery Equipment Revenue Forecast (2021-2026) (US$ Million)
Figure 89. Japan Subcutaneous Drug Delivery Equipment Production Forecast (2021-2026) (K Units)
Figure 90. Japan Subcutaneous Drug Delivery Equipment Revenue Forecast (2021-2026) (US$ Million)
Figure 91. Global Subcutaneous Drug Delivery Equipment Consumption Market Share Forecast by Region (2021-2026)
Figure 92. Subcutaneous Drug Delivery Equipment Value Chain
Figure 93. Channels of Distribution
Figure 94. Distributors Profiles
Figure 95. Porter's Five Forces Analysis
Figure 96. Bottom-up and Top-down Approaches for This Report
Figure 97. Data Triangulation
Figure 98. Key Executives Interviewed
  • Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
    Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118
    The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......
  • Global Non-imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90
    The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
  • Global PCR Equipment Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77
    The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......
  • Global Disposable Sterile Syringes and Needles Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109
    The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......
  • Global Orthopaedic Power Tools Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
  • Global Cerebrospinal Fluid Management Devices Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
  • Global CAD & CAM Milling Burs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
  • Global Artificial Teeth Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98
    The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs